More than 100 patients may have been infected by a "superbug" bacteria during procedures at the UCLA Health System and 2 have died.
More than 100 patients may have been infected by a “superbug” bacterium during procedures at the UCLA Health System, according to a recent statement.
These patients were exposed to the bacteria during endoscopic procedures between October 2014 and January 2015 at Ronald Reagan UCLA Medical Center. A total of 7 patients have been infected and 2 have died.
“…an internal investigation determined that carbapenem-resistant Enterobacteriaceae (CRE) bacteria may have been transmitted during a procedure that uses this specialized scope to diagnose and treat pancreaticobiliary diseases and may have been a contributing factor in the death of two patients,” according to a statement from the health system.
The potentially infected patients are being offered free home testing kits that UCLA would analyze. According to the CDC, up to half of patients who contract CRE are killed by the bacteria.
The Associated Press reported that 179 total patients were exposed to this deadly superbug resistant to antibiotics. UCLA said that the scopes were sterilized according to the manufacturer’s standards.
This is not the first time such an incident has occurred. In 2013, 44 Illinois residents were infected with CRE. Bacteria were found on 3 endoscopic devices, but there were no problems found with the hospital’s cleaning methods, according to the Wall Street Journal.
A study from the Medical University of South Carolina from September found that the chances of infections acquired in the hospital becoming drug resistant increase 1% for each day a patient is hospitalized. Furthermore, approximately 1 in 25 hospitalized patients have at least 1 hospital-acquired infection.
In fiscal year 2015, CMS will penalize more than 700 hospitals for poor performance in the Hospital-Acquired Condition Reduction Program, which is scored on patient safety and healthcare-associated infections. The program encourages hospitals to reduce hospital-acquired conditions and improve patient safety through financial incentives. This year, hospitals with high scores in hospital-acquired conditions will see their payments reduced by 1% for all discharges.
According to the Los Angeles Daily News, Ronald Reagan UCLA Medical Center was among the hospitals penalized for its score of 8.7 on a scale of 1 to 10.
Insurance Coverage Limits JAKi Therapy Access for Patients With AA, Especially Non-White Populations
April 25th 2024A survey study showed major barriers to Janus kinase inhibitor (JAKi) therapy for patients with alopecia areata, especially for non-White patients who face higher rates of being uninsured and struggle more to afford the treatment.
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Empowering Community Health Through Wellness and Faith
April 23rd 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In the third episode, Camille Clarke-Smith, EdD, MS, CHES, CPT, discusses approaching community health holistically through spiritual and community engagement.
Listen
Lack of Mutations Associated With Favorable Prognosis in MPN-U
April 25th 2024While the Dynamic International Prognostic Scoring System and bone marrow blasts may predict overall survival, the lack of certain mutations is also associated with a better prognosis for myeloproliferative neoplasm, unclassifiable (MPN-U).
Read More
What We’re Reading: FDA Approves UTI Antibiotic; Ozempic, Wegovy Price Investigation; US Births Fall
April 25th 2024The FDA recently approved an antibiotic for the treatment of urinary tract infections (UTIs) in women; a Senate committee recently launched an investigation into the prices of Novo Nordisk’s diabetes and weight loss drugs; US births fell last year, resuming a national slide after a previous increase during the pandemic.
Read More